Fate Therapeutics (FATE) Stock Forecast for 2023 – 2026. Sell or Buy?
Updated: December 2, 2023 (10:40)
Sector: HealthcareThe share price of Fate Therapeutics, Inc. (FATE) now
50/200 Day Moving Average: $2.074 / $4.191
This figure corresponds to the Average Price over the previous 50/200 days. For Fate Therapeutics stocks, the 50-day moving average is the support level today.
For Fate Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Fate Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Fate Therapeutics stock price in 2023, 2024, 2025, 2026, 2027. How much will one Fate Therapeutics share be worth in 2023 - 2027?
When should I take profit in Fate Therapeutics stock? When should I record a loss on Fate Therapeutics stock? What are analysts' forecasts for Fate Therapeutics stock? What is the future of Fate Therapeutics stock? We forecast Fate Therapeutics stock performance using neural networks based on historical data on Fate Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Fate Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Fate Therapeutics shares. This happens once a day.
Historical and forecast chart of Fate Therapeutics stock
The chart below shows the historical price of Fate Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Fate Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Fate Therapeutics, Inc. provides biopharmaceutical services. The company researches and develops therapies for the restoration and regeneration of body tissues using stem cells. The company operates in the USA.
Fate Therapeutics daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec 04 | 2.61 | 2.54 | 2.65 | 4.41 |
| Dec 05 | 2.62 | 2.58 | 2.69 | 4.09 |
| Dec 06 | 2.52 | 2.48 | 2.59 | 4.44 |
| Dec 07 | 2.56 | 2.53 | 2.63 | 3.84 |
| Dec 08 | 2.62 | 2.57 | 2.66 | 3.47 |
| Dec 09 | 2.58 | 2.54 | 2.60 | 2.48 |
| Dec 10 | 2.53 | 2.49 | 2.55 | 2.52 |
| Dec 11 | 2.58 | 2.53 | 2.61 | 3.17 |
| Dec 12 | 2.65 | 2.57 | 2.73 | 5.98 |
| Dec 13 | 2.63 | 2.60 | 2.67 | 2.92 |
| Dec 14 | 2.55 | 2.49 | 2.60 | 4.58 |
| Dec 15 | 2.56 | 2.50 | 2.60 | 4.22 |
| Dec 16 | 2.53 | 2.47 | 2.57 | 4.35 |
| Dec 17 | 2.57 | 2.51 | 2.64 | 5.08 |
| Dec 18 | 2.55 | 2.52 | 2.61 | 3.36 |
| Dec 19 | 2.53 | 2.50 | 2.59 | 3.57 |
| Dec 20 | 2.61 | 2.54 | 2.69 | 5.70 |
| Dec 21 | 2.64 | 2.59 | 2.68 | 3.38 |
| Dec 22 | 2.59 | 2.53 | 2.65 | 4.59 |
| Dec 23 | 2.51 | 2.48 | 2.58 | 4.29 |
| Dec 24 | 2.54 | 2.52 | 2.62 | 4.03 |
| Dec 25 | 2.44 | 2.37 | 2.51 | 5.76 |
| Dec 26 | 2.53 | 2.48 | 2.60 | 4.73 |
| Dec 27 | 2.61 | 2.58 | 2.66 | 3.24 |
| Dec 28 | 2.58 | 2.52 | 2.65 | 5.28 |
| Dec 29 | 2.54 | 2.51 | 2.58 | 2.99 |
| Dec 30 | 2.46 | 2.39 | 2.52 | 5.14 |
| Dec 31 | 2.43 | 2.36 | 2.50 | 5.93 |
| Jan 01 | 2.35 | 2.32 | 2.39 | 2.96 |
| Jan 02 | 2.38 | 2.32 | 2.44 | 5.19 |
Fate Therapeutics Daily Price Targets
Fate Therapeutics Stock Forecast 12-04-2023.
Forecast target price for 12-04-2023: $2.61.
Negative dynamics for Fate Therapeutics shares will prevail with possible volatility of 4.223%.
Pessimistic target level: 2.54
Optimistic target level: 2.65
Fate Therapeutics Stock Forecast 12-05-2023.
Forecast target price for 12-05-2023: $2.62.
Positive dynamics for Fate Therapeutics shares will prevail with possible volatility of 3.932%.
Pessimistic target level: 2.58
Optimistic target level: 2.69
Fate Therapeutics Stock Forecast 12-06-2023.
Forecast target price for 12-06-2023: $2.52.
Negative dynamics for Fate Therapeutics shares will prevail with possible volatility of 4.253%.
Pessimistic target level: 2.48
Optimistic target level: 2.59
Fate Therapeutics Stock Forecast 12-07-2023.
Forecast target price for 12-07-2023: $2.56.
Positive dynamics for Fate Therapeutics shares will prevail with possible volatility of 3.699%.
Pessimistic target level: 2.53
Optimistic target level: 2.63
Fate Therapeutics Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $2.62.
Positive dynamics for Fate Therapeutics shares will prevail with possible volatility of 3.356%.
Pessimistic target level: 2.57
Optimistic target level: 2.66
Fate Therapeutics Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $2.58.
Negative dynamics for Fate Therapeutics shares will prevail with possible volatility of 2.421%.
Pessimistic target level: 2.54
Optimistic target level: 2.60
FATE (FATE) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec. | 2.28 | 2.03 | 2.41 | 15.87 |
Fate Therapeutics forecast for this year
Fate Therapeutics Stock Prediction for Dec 2023
An downtrend is forecast for this month with an optimal target price of $2.2774. Pessimistic: $2.03. Optimistic: $2.41
Fate Therapeutics (FATE) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.14 | 2.08 | 2.22 | 5.96 |
| Feb | 2.17 | 1.99 | 2.28 | 12.78 |
| Mar | 2.05 | 1.89 | 2.15 | 12.10 |
| Apr | 1.89 | 1.79 | 2.02 | 11.24 |
| May | 2.01 | 1.85 | 2.21 | 16.17 |
| Jun | 1.96 | 1.77 | 2.09 | 15.35 |
| Jul | 1.85 | 1.72 | 2.04 | 15.39 |
| Aug | 1.73 | 1.62 | 1.82 | 11.15 |
| Sep | 1.54 | 1.45 | 1.66 | 12.89 |
| Oct | 1.63 | 1.56 | 1.73 | 9.52 |
| Nov | 1.41 | 1.36 | 1.53 | 11.42 |
| Dec | 1.34 | 1.27 | 1.44 | 12.19 |
Fate Therapeutics (FATE) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.26 | 1.21 | 1.35 | 10.82 |
| Feb | 1.21 | 1.17 | 1.29 | 9.28 |
| Mar | 1.15 | 1.03 | 1.24 | 17.01 |
| Apr | 1.15 | 1.08 | 1.28 | 16.01 |
| May | 1.12 | 1.02 | 1.22 | 16.23 |
| Jun | 1.19 | 1.11 | 1.27 | 12.61 |
| Jul | 1.22 | 1.10 | 1.31 | 16.27 |
| Aug | 1.28 | 1.24 | 1.41 | 11.72 |
| Sep | 1.25 | 1.19 | 1.37 | 13.74 |
| Oct | 1.14 | 1.02 | 1.25 | 18.95 |
| Nov | 1.17 | 1.11 | 1.28 | 13.29 |
| Dec | 1.11 | 0.98 | 1.16 | 14.89 |
Fate Therapeutics (FATE) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.04 | 1.01 | 1.14 | 11.86 |
| Feb | 1.11 | 1.03 | 1.22 | 15.96 |
| Mar | 1.04 | 0.96 | 1.15 | 16.53 |
| Apr | 0.94 | 0.86 | 1.03 | 15.85 |
| May | 0.82 | 0.76 | 0.87 | 12.71 |
| Jun | 0.83 | 0.79 | 0.89 | 10.93 |
| Jul | 0.83 | 0.79 | 0.89 | 10.70 |
| Aug | 0.94 | 0.90 | 0.98 | 8.58 |
| Sep | 0.91 | 0.86 | 1.01 | 15.00 |
| Oct | 0.99 | 0.90 | 1.07 | 15.63 |
| Nov | 1.01 | 0.92 | 1.05 | 11.78 |
| Dec | 1.03 | 0.99 | 1.06 | 6.91 |
Fate Therapeutics (FATE) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.06 | 0.99 | 1.17 | 14.95 |
| Feb | 1.13 | 1.09 | 1.19 | 9.11 |
| Mar | 1.03 | 0.94 | 1.06 | 11.03 |
| Apr | 1.10 | 1.06 | 1.17 | 8.94 |
| May | 1.06 | 1.00 | 1.12 | 11.37 |
| Jun | 1.12 | 1.07 | 1.24 | 13.40 |
| Jul | 1.18 | 1.11 | 1.24 | 10.00 |
| Aug | 1.18 | 1.09 | 1.31 | 16.66 |
| Sep | 1.16 | 1.10 | 1.29 | 14.89 |
| Oct | 1.24 | 1.19 | 1.38 | 14.10 |
| Nov | 1.23 | 1.13 | 1.27 | 11.50 |
| Dec | 1.35 | 1.20 | 1.45 | 17.18 |
Fate Therapeutics information and performance
3535 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, US
Market capitalization of the Fate Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of FATE shares in the company outstanding by the market price of one share.
EBITDA of Fate Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Related stocks from Healthcare sector
